NL7304437A - - Google Patents

Info

Publication number
NL7304437A
NL7304437A NL7304437A NL7304437A NL7304437A NL 7304437 A NL7304437 A NL 7304437A NL 7304437 A NL7304437 A NL 7304437A NL 7304437 A NL7304437 A NL 7304437A NL 7304437 A NL7304437 A NL 7304437A
Authority
NL
Netherlands
Application number
NL7304437A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7304437A publication Critical patent/NL7304437A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/40—Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/80—Oxygen atoms
    • C07D239/82—Oxygen atoms with an aryl radical attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL7304437A 1972-03-31 1973-03-30 NL7304437A (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3296672A JPS5427356B2 (enExample) 1972-03-31 1972-03-31

Publications (1)

Publication Number Publication Date
NL7304437A true NL7304437A (enExample) 1973-10-02

Family

ID=12373638

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7304437A NL7304437A (enExample) 1972-03-31 1973-03-30

Country Status (10)

Country Link
US (1) US3923710A (enExample)
JP (1) JPS5427356B2 (enExample)
AT (1) AT326668B (enExample)
CA (1) CA949572A (enExample)
CH (1) CH589070A5 (enExample)
DK (1) DK132948C (enExample)
HU (1) HU166021B (enExample)
NL (1) NL7304437A (enExample)
PL (1) PL91816B1 (enExample)
SE (1) SE399255B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4202895A (en) * 1971-06-04 1980-05-13 Sumitomo Chemical Company, Limited 1-Polyhaloalkyl-2(1H)-quinazolinone derivatives
US8440693B2 (en) 2009-12-22 2013-05-14 Novartis Ag Substituted isoquinolinones and quinazolinones
SI2640467T1 (sl) 2010-11-19 2015-04-30 Novartis Ag Kristalinična oblika inhibitorja interakcije MDM2/4 in P53
EP2855483B1 (en) 2012-05-24 2017-10-25 Novartis AG Pyrrolopyrrolidinone compounds
WO2014115080A1 (en) 2013-01-22 2014-07-31 Novartis Ag Pyrazolo[3,4-d]pyrimidinone compounds as inhibitors of the p53/mdm2 interaction
US9403827B2 (en) 2013-01-22 2016-08-02 Novartis Ag Substituted purinone compounds
CN105209467B (zh) 2013-05-27 2018-06-08 诺华股份有限公司 咪唑并吡咯烷酮衍生物及其在治疗疾病中的用途
AU2014272695B2 (en) 2013-05-28 2016-10-20 Novartis Ag Pyrazolo-pyrrolidin-4-one derivatives as BET inhibitors and their use in the treatment of disease
WO2014191911A1 (en) 2013-05-28 2014-12-04 Novartis Ag Pyrazolo-pyrrolidin-4-one derivatives and their use in the treatment of disease
MX2016006667A (es) 2013-11-21 2016-07-26 Novartis Ag Derivados de pirrolo-pirrolona y su uso como inhibidores.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3712892A (en) * 1969-08-02 1973-01-23 Sumitomo Chemical Co Quinazolinone derivatives

Also Published As

Publication number Publication date
ATA267973A (de) 1975-03-15
DK132948C (da) 1976-07-26
HU166021B (enExample) 1974-12-28
JPS5427356B2 (enExample) 1979-09-10
JPS4899186A (enExample) 1973-12-15
US3923710A (en) 1975-12-02
AT326668B (de) 1975-12-29
PL91816B1 (enExample) 1977-03-31
CA949572A (en) 1974-06-18
CH589070A5 (enExample) 1977-06-30
SE399255B (sv) 1978-02-06
DK132948B (da) 1976-03-01

Similar Documents

Publication Publication Date Title
FR2188827A5 (enExample)
JPS5216847B2 (enExample)
JPS5427356B2 (enExample)
JPS4938613A (enExample)
JPS5115629Y2 (enExample)
JPS4967651A (enExample)
JPS528215Y2 (enExample)
JPS5619985B2 (enExample)
JPS4894185U (enExample)
JPS4881431A (enExample)
JPS4958096A (enExample)
JPS4964734U (enExample)
CH566258A5 (enExample)
CH561632A5 (enExample)
CH576991A5 (enExample)
CH566534A5 (enExample)
CH569955A5 (enExample)
CH575128A5 (enExample)
CH574977A5 (enExample)
CH575946A5 (enExample)
CH563042A5 (enExample)
CH560847A5 (enExample)
CH563177A5 (enExample)
CH566827A5 (enExample)
CH592161A5 (enExample)

Legal Events

Date Code Title Description
BV The patent application has lapsed